AUD 0.02
(N/A%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 | 1.1 Million AUD | -26.98% |
2023 | 1.51 Million AUD | -7.39% |
2022 | 1.63 Million AUD | 207.71% |
2021 | 532 Thousand AUD | -7.16% |
2020 | 573 Thousand AUD | -90.99% |
2019 | 6.35 Million AUD | -2.02% |
2018 | 6.48 Million AUD | -5.7% |
2017 | 6.88 Million AUD | 92.23% |
2016 | 3.57 Million AUD | 33.99% |
2015 | 2.67 Million AUD | -46.17% |
2014 | 4.96 Million AUD | 22.64% |
2013 | 4.04 Million AUD | 46.59% |
2012 | 2.76 Million AUD | 6.24% |
2011 | 2.59 Million AUD | 33.23% |
2010 | 1.95 Million AUD | -0.41% |
2009 | 1.95 Million AUD | -4.3% |
2008 | 2.04 Million AUD | 6.18% |
2007 | 1.92 Million AUD | 0.0% |
2005 | - AUD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q4 | 1.15 Million AUD | 0.0% |
2024 FY | 1.82 Million AUD | 20.25% |
2024 Q2 | 519 Thousand AUD | 0.0% |
2023 Q2 | 523 Thousand AUD | 0.0% |
2023 Q4 | 770 Thousand AUD | 0.0% |
2023 FY | 1.51 Million AUD | -7.39% |
2022 FY | 1.63 Million AUD | 207.71% |
2022 Q4 | 1.02 Million AUD | 0.0% |
2022 Q2 | 276 Thousand AUD | 0.0% |
2021 Q4 | 323 Thousand AUD | 0.0% |
2021 FY | 532 Thousand AUD | -7.16% |
2021 Q2 | 209 Thousand AUD | 0.0% |
2020 Q2 | 366 Thousand AUD | 0.0% |
2020 Q4 | 207 Thousand AUD | 0.0% |
2020 FY | 573 Thousand AUD | -90.99% |
2019 FY | 6.35 Million AUD | -2.02% |
2019 Q4 | 1.17 Million AUD | 0.0% |
2019 Q2 | 2.65 Million AUD | 0.0% |
2018 FY | 6.48 Million AUD | -5.7% |
2018 Q4 | 8.16 Million AUD | 0.0% |
2018 Q2 | 2.03 Million AUD | 0.0% |
2017 Q2 | 1.32 Million AUD | 0.0% |
2017 Q4 | 6.63 Million AUD | 0.0% |
2017 FY | 6.88 Million AUD | 92.23% |
2016 Q2 | 1.95 Million AUD | 0.0% |
2016 Q4 | 1.62 Million AUD | 0.0% |
2016 FY | 3.57 Million AUD | 33.99% |
2015 Q4 | 1.28 Million AUD | 0.0% |
2015 FY | 2.67 Million AUD | -46.17% |
2015 Q2 | 1.38 Million AUD | 0.0% |
2014 FY | 4.96 Million AUD | 22.64% |
2014 Q2 | 2.34 Million AUD | 0.0% |
2014 Q4 | 2.61 Million AUD | 0.0% |
2013 Q2 | 1.93 Million AUD | 0.0% |
2013 FY | 4.04 Million AUD | 46.59% |
2013 Q4 | 2.11 Million AUD | 0.0% |
2012 Q2 | 180 Thousand AUD | -4.51% |
2012 Q3 | 180 Thousand AUD | 0.0% |
2012 Q4 | 180 Thousand AUD | 0.0% |
2012 FY | 2.76 Million AUD | 6.24% |
2012 Q1 | 188.5 Thousand AUD | 0.0% |
2011 FY | 2.59 Million AUD | 33.23% |
2011 Q2 | 188.5 Thousand AUD | 77.83% |
2011 Q1 | 106 Thousand AUD | 0.0% |
2011 Q3 | 188.5 Thousand AUD | 0.0% |
2011 Q4 | 188.5 Thousand AUD | 0.0% |
2010 Q2 | 106 Thousand AUD | -25.48% |
2010 FY | 1.95 Million AUD | -0.41% |
2010 Q1 | 142.25 Thousand AUD | 0.0% |
2010 Q4 | 106 Thousand AUD | 0.0% |
2010 Q3 | 106 Thousand AUD | 0.0% |
2009 Q4 | 142.25 Thousand AUD | 0.0% |
2009 Q3 | 142.25 Thousand AUD | 0.0% |
2009 Q1 | 163 Thousand AUD | 0.0% |
2009 Q2 | 142.25 Thousand AUD | -12.73% |
2009 FY | 1.95 Million AUD | -4.3% |
2008 Q2 | 163 Thousand AUD | -27.76% |
2008 Q3 | 163 Thousand AUD | 0.0% |
2008 FY | 2.04 Million AUD | 6.18% |
2008 Q4 | 163 Thousand AUD | 0.0% |
2008 Q1 | 225.64 Thousand AUD | 0.0% |
2007 Q3 | 225.64 Thousand AUD | 0.0% |
2007 FY | 1.92 Million AUD | 0.0% |
2007 Q2 | 225.64 Thousand AUD | 0.0% |
2007 Q4 | 225.64 Thousand AUD | 0.0% |
2006 Q1 | - AUD | 0.0% |
2005 Q3 | - AUD | 0.0% |
2005 FY | - AUD | 0.0% |
2005 Q2 | - AUD | 0.0% |
2005 Q4 | - AUD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
4DMedical Limited | 31.48 Million AUD | 96.484% |
Adherium Limited | 267.7 Thousand AUD | -313.518% |
Aroa Biosurgery Limited | 66.09 Million AUD | 98.325% |
Atomo Diagnostics Limited | 1.6 Million AUD | 31.071% |
Anteris Technologies Ltd | 69.14 Million AUD | 98.399% |
Control Bionics Limited | 9.82 Million AUD | 88.734% |
CardieX Limited | 16.64 Million AUD | 93.351% |
Compumedics Limited | 26.88 Million AUD | 95.882% |
Cochlear Limited | 1.17 Billion AUD | 99.906% |
CleanSpace Holdings Limited | 11.35 Million AUD | 90.255% |
Cyclopharm Limited | 13.38 Million AUD | 91.727% |
EMVision Medical Devices Ltd | 12.83 Million AUD | 91.374% |
Nova Eye Medical Limited | 23.99 Million AUD | 95.386% |
HeraMED Limited | 6.78 Million AUD | 83.68% |
Imricor Medical Systems, Inc. | -1.11 Million AUD | 199.208% |
ImpediMed Limited | 28.04 Million AUD | 96.052% |
InhaleRx Limited | 2.59 Million AUD | 57.267% |
Micro-X Limited | 18.76 Million AUD | 94.1% |
Neurotech International Limited | 8.75 Million AUD | 87.355% |
OncoSil Medical Limited | 12.03 Million AUD | 90.806% |
PolyNovo Limited | 34.92 Million AUD | 96.83% |
Respiri Limited | 8.03 Million AUD | 86.223% |
SomnoMed Limited | 58.97 Million AUD | 98.123% |
Universal Biosensors, Inc. | 20 Million AUD | 94.465% |
Uscom Limited | 5.52 Million AUD | 79.946% |
Visioneering Technologies, Inc. | 9.63 Million AUD | 88.509% |